Predicting mortality by the Glasgow alcoholic hepatitis score: The long awaited progress?

Gut

Volumn 54, Issue 8, 2005, Pages 1057-1059

  Tilg, H ^a   Kaser, A ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CORTICOSTEROID; LAMININ; PLACEBO; PROTEIN P55; PROTEIN P75; STEROID; TUMOR NECROSIS FACTOR RECEPTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL LIVER DISEASE; ANOREXIA; BILIRUBIN BLOOD LEVEL; BLOOD CLOTTING DISORDER; CHILD TURCOTTE PUGH SCORE; CLINICAL FEATURE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFICACY; FEVER; GLASGOW ALCOHOLIC HEPATITIS SCORE; HEPATIC ENCEPHALOPATHY; HEPATOMEGALY; HIGH RISK PATIENT; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; JAUNDICE; LEUKOCYTE COUNT; LEUKOCYTOSIS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FAILURE; MELD SCORE; MORTALITY; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTHROMBIN TIME; SCORING SYSTEM; SURVIVAL;

FATTY LIVER; HEPATITIS, ALCOHOLIC; HUMANS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 22644446080     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.063420     Document Type: Note

References (21)

1. Tome S, Lucey MR. Review article: current management of alcoholic liver disease. Aliment Pharmacol Ther 2004;19:707-14.
2. Orrego H, Blake JE, Blendis LM, et al. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 1987;92:208-14.
3. Chedid A, Mendenhall CL, Gartside P, et al. Prognostic factors in alcoholic liver disease. VA Cooperative Study Group. Am J Gastroenterol 1991;86:210-16.
4. Maddrey WC, Boitnott JK, Bedine MS, et al. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193-9.
5. Carithers RL Jr, Herlong HF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989;110:685-90.
6. Mathurin P, Mendenhall CL, Carithers RL Jr, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002;36:480-7.
7. McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. Am J Gastroenterol 1998;93:2022-36.
8. Sheth M, Riggs M, Patel T. Utility of the Mayo end-stage liver disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002;2:2.
9. Stewart SF, Day CP. The management of alcoholic liver disease. J Hepatol 2003;38(suppl 1):S2-13.
10. Said A, Williams J, Holden J, et al. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004;40:897-903.
11. Kulkarni K, Tran T, Medrano M, et al. The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis. J Clin Gastroenterol 2004;38:453-9.
12. Forrest EH, Evans CDJ, Stewart S, et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005;54:1174-9.
13. Kumashiro R, Sata M, Ishii K, et al. Prognostic factors for short-term survival in alcoholic hepatitis in Japan: analysis by logistic regression. Alcohol Clin Exp Res 1996;20(suppl 9): 383A-6A.
14. Mathurin P, Duchatelle V, Ramond MJ, et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996;110:1847-53.
15. Dufour DR, Lott JA, Nolte FS, et al. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clin Chem 2000;46:2050-68.
16. Fujimoto M, Uemura M, Kojima H, et al. Prognostic factors in severe alcoholic liver injury. Nara Liver Study Group. Alcohol Clin Exp Res 1999;23(suppl):33-8S.
17. Naveau S, Emilie D, Balian A, et al. Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity. J Hepatol 1998;28:778-84.
18. Spahr L, Giostra E, Frossard JL, et al. Soluble TNF-R1, but not tumor necrosis factor alpha, predicts the 3-month mortality in patients with alcoholic hepatitis. J Hepatol 2004;41:229-34.
19. Castera L, Hartmann DJ, Chapel F, et al. Serum laminin and type IV collagen are accurate markers of histologically severe alcoholic hepatitis in patients with cirrhosis. J Hepatol 2000;32:412-8.
20. Mathurin P, Abdelnour M, Ramond MJ, et al. Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone. Hepatology 2003;38:1363-9.
21. Duvoux C, Radier C, Roudot-Thoraval F, et al. Low-grade steatosis and major changes in portal flow as new prognostic factors in steroid-treated alcoholic hepatitis. Hepatology 2004;40:1370-8.